INFECTIOUS DISEASES SOCIETY OF AMERICA for INFECTIOUS DISEASES SOCIETY OF AMERICA
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report | Jan 16, 2009 | $116,112 | Replaced |
| 4th Quarter - Report (this page) | Jan 20, 2010 | $115,820 | Replaced |
| 4th Quarter - Amendment | Jan 20, 2010 | $115,820 | Replaced |
| 4th Quarter - Amendment | Jun 22, 2010 | $115,820 | Yes |
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
Medical liability; Antimicrobial resistance research; Infectious diseases product research and development; Unnecessary regulatory burdens placed on medical research; Support for evidence-based decision making.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT J GUIDOS | V.P. Public Policy & Government Relations |
| KIMBERLY ANN MILLER | HIV Medicine Association Policy Officer |
| R MICHAEL OCHS | Government Relations Associate |
| ANDREA WEDDLE | Executive Director, HIV Medical Association |
Health Issues HCR
Infectious Diseases; drug and vaccine research and development; antimicrobial resistance; hospital-acquired infections; immunizations; pandemic influenza, public health security and biodefense; global infectious diseases; biomedical research, reauthorization of President's Emergency Plan for AIDS Relief (PEPFAR); Lyme disease and other infectious diseases issues; Ryan White reauthorization; Strategies to Address Antimicrobial Resistance Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT J GUIDOS | V.P. Public Policy & Government Relations |
| KIMBERLY ANN MILLER | HIV Medicine Association Policy Officer |
| R MICHAEL OCHS | Government Relations Associate |
| ANDREA WEDDLE | Executive Director, HIV Medicine Association |
Medicare/Medicaid MMM
Reimbursement for outpatient infusion therapy; Physician payments; Medicaid and Medicare, including Medicare Prescription Drug Coverage; Average Sales Price; Competitive Acquistion Program; and Healthcare Reform.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT J GUIDOS | V.P. Public Policy & Government Relations |
| KIMBERLY ANN MILLER | HIV Medicine Association Policy Officer |
| R MICHAEL OCHS | Government Relations Associate |
| JASON SCULL | Program Officer for Clinical Affaiars |
| ANDREA WEDDLE | Executive Director, HIV Medicine Association |
Budget/Appropriations BUD
Funding support for the Department of Health and Human Services, Centers for Disease Control and Prevention, National Institutes of Health, Health Resources & Services Administration, Food & Drug Administration and global programs for various infectious diseases related issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT J GUIDOS | V.P. Public Policy & Government Relations |
| KIMBERLY ANN MILLER | HIV Medical Association Policy Officer |
| R MICHAEL OCHS | Government Relations Associate |
| ANDREA WEDDLE | Executive Director, HIV Medical Association |
Affiliated organisations
| Organisation | Location |
|---|---|
| HIV MEDICINE ASSOCIATIONS | Arlington, VA, US |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.